Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neel Belani

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Expert Opinion on Biological Therapy|June 14, 2025
An evaluation of datopotamab deruxtecan for the treatment of non-small cell lung cancerNeel Belani, Anjali Donnelly, Alexander Spira
Rhode Island Medical Journal (2013)|March 2, 2021
Non-Bacterial Thrombotic Endocarditis as a Cause of Cryptogenic Stroke in MalignancySuleman Ilyas, William Lang, Neel Belani, et al.
JACC. Cardiooncology|August 24, 2023
How to Treat <i>EGFR</i>-Mutated Non-Small Cell Lung CancerNeel Belani, Katherine Liang, Michael Fradley, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 27, 2021
Use of antibiotics is associated with worse clinical outcomes in patients with cancer treated with immune checkpoint inhibitors: A systematic review and meta-analysisMaria Tsikala-Vafea, Neel Belani, Kendra Vieira, et al.
Targeted Oncology|December 28, 2022
Emerging Biomarkers in Immune Oncology to Guide Lung Cancer ManagementHoussein Safa, Fawzi Abu Rous, Neel Belani, et al.
Advances in Therapy|May 29, 2025
Risk Factors Associated with Suboptimal Real-World Outcomes in Patients with EGFR-Mutated Non-Small Cell Lung Cancer Treated with Front-Line Recommended TherapyAlexander I Spira, Tao Ran, Iris Lin, et al.
Advances in Radiation Oncology|February 27, 2023
Predictors of Pneumonitis in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Definitive Chemoradiation Followed by Consolidative DurvalumabBrett H Diamond, Neel Belani, Rebecca Masel, et al.
Cancer Discovery|January 8, 2024
Targeting DHX9 Triggers Tumor-Intrinsic Interferon Response and Replication Stress in Small Cell Lung CancerTakahiko Murayama, Jun Nakayama, Xinpei Jiang, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Expert Opinion on Biological Therapy|June 14, 2025
An evaluation of datopotamab deruxtecan for the treatment of non-small cell lung cancerNeel Belani, Anjali Donnelly, Alexander Spira
Rhode Island Medical Journal (2013)|March 2, 2021
Non-Bacterial Thrombotic Endocarditis as a Cause of Cryptogenic Stroke in MalignancySuleman Ilyas, William Lang, Neel Belani, et al.
JACC. Cardiooncology|August 24, 2023
How to Treat <i>EGFR</i>-Mutated Non-Small Cell Lung CancerNeel Belani, Katherine Liang, Michael Fradley, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 27, 2021
Use of antibiotics is associated with worse clinical outcomes in patients with cancer treated with immune checkpoint inhibitors: A systematic review and meta-analysisMaria Tsikala-Vafea, Neel Belani, Kendra Vieira, et al.
Targeted Oncology|December 28, 2022
Emerging Biomarkers in Immune Oncology to Guide Lung Cancer ManagementHoussein Safa, Fawzi Abu Rous, Neel Belani, et al.
Advances in Therapy|May 29, 2025
Risk Factors Associated with Suboptimal Real-World Outcomes in Patients with EGFR-Mutated Non-Small Cell Lung Cancer Treated with Front-Line Recommended TherapyAlexander I Spira, Tao Ran, Iris Lin, et al.
Advances in Radiation Oncology|February 27, 2023
Predictors of Pneumonitis in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Definitive Chemoradiation Followed by Consolidative DurvalumabBrett H Diamond, Neel Belani, Rebecca Masel, et al.
Cancer Discovery|January 8, 2024
Targeting DHX9 Triggers Tumor-Intrinsic Interferon Response and Replication Stress in Small Cell Lung CancerTakahiko Murayama, Jun Nakayama, Xinpei Jiang, et al.
Pageof 1